Tissue and serum adiponectin levels in patients with gastric cancer: Are there any correlations between adiponectin levels and histopathological variables?

Hepato-Gastroenterology

Volumn 58, Issue 110-111, 2011, Pages 1841-1846

  Seker, Mesut ^a   Bilici, Ahmet ^a   Guler, Derya Oztas ^a   Ustaaliogľu, Bala Basak ^a   Gozu, Hul̈ya ^a   Erkal, Fatih Yavuz ^a   Sonmez, Berkant ^a   Karaduman, Mehmet ^a   Kefeli, Umut ^a   Yildirim, Emre ^a   Salepciand, Taflan ^a   Gumus, Mahmut ^a  

^a DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Adiponectin; Gastric cancer; Insulin resistance

Indexed keywords

ADIPONECTIN;

AGED; ARTICLE; BREAST; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH CANCER;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 83355174162     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Calle EE, Rodriguez C, Walker-Thurmond K, et al.: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348:1625-38. (Pubitemid 36459468)
2. Bergstrom A, Pisani P, Tenet V, et al.: Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001; 91:421-30. (Pubitemid 32049639)
3. Lagergren J, Bergstrom R, Nyren O: Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999; 130:883-90. (Pubitemid 29239582)
4. Vaughan TL, Farrow DC, Hansten PD, et al.: Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux. Cancer Epidemiol Biomarkers Prev 1998; 7:749-56. (Pubitemid 28420612)
5. Ishikawa M, Kitayama J, Kazama S, et al.: Plasma adiponectin and gastric cancer. Clin Cancer Res 2005; 11:466-72. (Pubitemid 40116868)
6. Fraser-Moodie CA, Norton B, Gornall C, et al.: Weight loss has an independent beneficial effect on symptoms of gastrooesophageal reflux in patients who are overweight. Scand J Gastroenterol 1999; 34:337-40. (Pubitemid 29232366)
7. Terry P, Lagergren J, Wolk A, et al.: Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia Nutr Cancer 2000; 38:186-91. (Pubitemid 32762018)
8. Guerre-Millo M: Adipose tissue and adipokines: for better or worse. Diabetes Metab 2004; 30:13-9.
9. Maeda K, Okubo K, Shimomura I, et al.: Analysis of an expression profile of genes in the human adipose tissue. Gene 1997; 190:227-35. (Pubitemid 27220127)
10. Stefan N, Stumvoll M: Adiponectin - its role in metabolism and beyond. Horm Metab Res 2002; 34:469-474. (Pubitemid 35192231)
11. Arita Y, Kihara S, Ouchi N, et al.: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83. (Pubitemid 29299050)
12. Weyer C, Funahashi T, Tanaka S, et al.: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86:1930-1935. (Pubitemid 32472900)
13. Matsubara M, Maruoka S, Katayose S: Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002;87:2764-2769 (Pubitemid 34655342)
14. Hotta K, Funahashi T, Arita Y, et al.: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-1599. (Pubitemid 30353893)
15. Lindsay RS, Funahashi T, Hanson RL, et al.: Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002;360:57-58. (Pubitemid 34756495)
16. Vozarova B, Stefan N, Lindsay RS, et al.: Low plasma adiponectin concentrations do not predict weight gain in humans. Diabetes 2002;51:2964-2967.
17. Dal Maso L, Augustin LS, Karalis A, et al.: Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 2004; 89:1160-3. (Pubitemid 38368405)
18. Mantzoros C, Petridou E, Dessypris N, et al.: Adiponectin and breast cancer risk. J Clin Endocrinol Metab 2004; 89:1102-7. (Pubitemid 38368397)
19. Miyoshi Y, Funahashi T, Kihara S, et al.: Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 2003;9:5699-704. (Pubitemid 37499493)
20. Nakajima TE, Yamada Y, Hamano T, et al.: Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer. J Gastroenterol 2009; 44:685-90.
21. Rose DP, Komninou D, Stephenson GD: Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 2004; 5(3):153-65. (Pubitemid 38998240)
22. Matsubara M, Maruoka S, Katayose S: Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 2002; 147(2):173-80.
23. Seker M, Bilici A, Sonmez B, Ustaalioǧlu BB, Gumus M, Gozu H, Sargin M, Orcun A, Gezen C, Eser M, Bildik N, Salepci T: The association of serum adiponectin levels with histopathological variables in gastric cancer patients. Med Oncol 2010; 27:1319-23.
24. Wei EK, Giovannucci E, Fuchs CS, et al.: Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005; 97:1688-94. (Pubitemid 41672235)
25. Dalamaga M, Karmaniolas K, Nikolaidou A, et al.: Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system. Eur J Cancer 2008; 44:1744-53.
26. Karaduman M, Bilici A, Ozet A, Sengul A, Musabak U, Alomeroglu M: Tissue levels of adiponectin in breast cancer patients. Med Oncol 2007; 24(4):361-6. (Pubitemid 350135926)
27. Sonmez B, Seker M, Bilici A, Yavuz Erkal F, Oven Ustalioglu BB, Gumus M, Ozturk Guler D, Karaduman M, Gezen C, Eser M, Bildik N, Salepci T: Is there any correlation among adiponectin levels in serum, tumor tissue and normal tissue of the same patients with breast cancer? J BUON. 2011; 16:227-32.